Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework

• Váldodahkkit: Aruna Korde (Dahkki), Marianne Patt (Dahkki), Svetlana V. Selivanova (Dahkki), Andrew M. Scott (Dahkki), Rolf Hesselmann (Dahkki), Oliver Kiss (Dahkki), Natesan Ramamoorthy (Dahkki), Sergio Todde (Dahkki), Sietske M. Rubow (Dahkki), Luther Gwaza (Dahkki), Serge Lyashchenko (Dahkki), Jan Andersson (Dahkki), Brian Hockley (Dahkki), Ravindra Kaslival (Dahkki), Clemens Decristoforo (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2024-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Nuclear medicine has made enormous progress in the past decades. However, there are still significant inequalities in patient access among different countries, which could be mitigated by improving access to and availability of radiopharmaceuticals. Main body This paper summarise...